Soo Jin Na1, Jeong Hoon Yang2, Ji-Hyuk Yang3, Kiick Sung3, Jin-Oh Choi2, Joo-Yong Hahn2, Eun-Seok Jeon2, Yang Hyun Cho3. 1. Department of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. 2. Division of Cardiology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. 3. Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Abstract
BACKGROUND: We aimed to investigate the effects and proper timing of left heart decompression (LHD) on the clinical outcomes of patients on venoarterial extracorporeal membrane oxygenation (VA ECMO). METHODS: Among 335 adult patients who underwent VA ECMO from January 2013 to December 2016, 50 who underwent LHD were analyzed. The patients were divided into two groups according to the timing of LHD: those in whom percutaneous LHD was performed at ECMO initiation (prophylactic LHD group, n=18) and those who required LHD to treat complications of impaired left ventricle (LV) unloading (therapeutic LHD group, n=32). RESULTS: Thirty-day mortality rates were 34.4% and 5.6% in the therapeutic and prophylactic LHD groups, respectively (P=0.036). The rate of successful weaning from ECMO (62.5% vs. 83.3%, P=0.123) and duration of ECMO support (10.5 vs. 15.4 days, P=0.332) were not significantly different between the groups. However, the rate of bridging to cardiac replacement therapy, such as heart transplantation or left ventricular assist device, was significantly higher in the prophylactic LHD group (66.7%) than in the therapeutic LHD group (37.5%) (P=0.048). CONCLUSIONS: Prophylactic percutaneous transseptal left atrial (LA) drainage at ECMO initiation appeared to be associated with a lower early mortality rate and a higher likelihood of successful bridging to cardiac replacement therapy than therapeutic LHD to treat complications of left ventricular distension. 2019 Journal of Thoracic Disease. All rights reserved.
BACKGROUND: We aimed to investigate the effects and proper timing of left heart decompression (LHD) on the clinical outcomes of patients on venoarterial extracorporeal membrane oxygenation (VA ECMO). METHODS: Among 335 adult patients who underwent VA ECMO from January 2013 to December 2016, 50 who underwent LHD were analyzed. The patients were divided into two groups according to the timing of LHD: those in whom percutaneous LHD was performed at ECMO initiation (prophylactic LHD group, n=18) and those who required LHD to treat complications of impaired left ventricle (LV) unloading (therapeutic LHD group, n=32). RESULTS: Thirty-day mortality rates were 34.4% and 5.6% in the therapeutic and prophylactic LHD groups, respectively (P=0.036). The rate of successful weaning from ECMO (62.5% vs. 83.3%, P=0.123) and duration of ECMO support (10.5 vs. 15.4 days, P=0.332) were not significantly different between the groups. However, the rate of bridging to cardiac replacement therapy, such as heart transplantation or left ventricular assist device, was significantly higher in the prophylactic LHD group (66.7%) than in the therapeutic LHD group (37.5%) (P=0.048). CONCLUSIONS: Prophylactic percutaneous transseptal left atrial (LA) drainage at ECMO initiation appeared to be associated with a lower early mortality rate and a higher likelihood of successful bridging to cardiac replacement therapy than therapeutic LHD to treat complications of left ventricular distension. 2019 Journal of Thoracic Disease. All rights reserved.
Authors: Karen L Booth; Stephen J Roth; Stanton B Perry; Pedro J del Nido; David L Wessel; Peter C Laussen Journal: J Am Coll Cardiol Date: 2002-11-06 Impact factor: 24.094
Authors: Charanjit S Rihal; Srihari S Naidu; Michael M Givertz; Wilson Y Szeto; James A Burke; Navin K Kapur; Morton Kern; Kirk N Garratt; James A Goldstein; Vivian Dimas; Thomas Tu Journal: J Am Coll Cardiol Date: 2015-04-07 Impact factor: 24.094
Authors: Lucas J Eastaugh; Ravi R Thiagarajan; Jeffrey R Darst; Doff B McElhinney; James E Lock; Audrey C Marshall Journal: Pediatr Crit Care Med Date: 2015-01 Impact factor: 3.624
Authors: Douglas F Hacking; Derek Best; Yves d'Udekem; Christian P Brizard; Igor E Konstantinov; Johnny Millar; Warwick Butt Journal: Artif Organs Date: 2014-10-20 Impact factor: 3.094
Authors: Michael M H Cheung; Allan P Goldman; Lara S Shekerdemian; Kate L Brown; Gordon A Cohen; Andrew N Redington Journal: Pediatr Crit Care Med Date: 2003-10 Impact factor: 3.624
Authors: Enzo Lüsebrink; Leonhard Binzenhöfer; Antonia Kellnar; Christoph Müller; Clemens Scherer; Benedikt Schrage; Dominik Joskowiak; Tobias Petzold; Daniel Braun; Stefan Brunner; Sven Peterss; Jörg Hausleiter; Sebastian Zimmer; Frank Born; Dirk Westermann; Holger Thiele; Andreas Schäfer; Christian Hagl; Steffen Massberg; Martin Orban Journal: Clin Res Cardiol Date: 2022-08-20 Impact factor: 6.138
Authors: E Wilson Grandin; Jose I Nunez; Brooks Willar; Kevin Kennedy; Peter Rycus; Joseph E Tonna; Navin K Kapur; Shahzad Shaefi; A Reshad Garan Journal: J Am Coll Cardiol Date: 2022-04-05 Impact factor: 27.203
Authors: Pavel Hála; Mikuláš Mlček; Petr Ošťádal; Michaela Popková; David Janák; Tomáš Bouček; Stanislav Lacko; Jaroslav Kudlička; Petr Neužil; Otomar Kittnar Journal: J Transl Med Date: 2020-02-13 Impact factor: 5.531
Authors: Pieter S van der Wal; Myrthe P J van Steenwijk; Leon J Montenij; Dirk W Donker; Christiaan L Meuwese Journal: J Thorac Dis Date: 2020-11 Impact factor: 2.895